Ureterosigmoidostomy after pelvic irradiation.
The records of 34 patients who underwent ureterosigmoidostomy after pelvic irradiation were reviewed and the incidence of complications was found to be similar to that in other series of ureterosigmoidostomy without prior irradiation. No difference was established between the use of linac or cobalt 60 therapy in relation to postoperative complications. No conclusions could be reached concerning the effect of the preoperative dose of radiotherapy on the operation because of the small number of patients but it did appear that the incidence of postoperative complications was great after doses in excess of 5,000 rads. Ureterosigmoidostomy after pelvic irradiation is considered to be a feasible procedure with doses of less than 5,000 rads.
D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D012809:Colon, Sigmoid / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010388:Pelvis / Q000528:radiation effects*; D011183:Postoperative Complications / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy / Q000601:surgery; D014547:Urinary Diversion
D003037:Cobalt Radioisotopes